EMJ GOLD: Pharma news, views and analysis

In this episode,  GOLD  talks to Liz Ashall-Payne, founder of ORCHA, a company that curates libraries of digital health apps for patients and healthcare professionals. She discusses the growing patient appetite for apps, the education that is needed for healthcare professionals and early considerations for pharma companies wishing to develop these solutions.  GOLD  also speaks to Dario Safaric, fo...

In this episode,  GOLD  talks to Wayne Best, Chief Creative Officer, VMLY&R, who offers his insights on the innovative 'I Will Always Be Me' project with the MND Association – a fascinating and important cause with so much potential to inspire the pharma industry. But that's not all! Join us to delve into the latest  GOLD  infographic on supply chain stability and hear the latest industry news you...

The GOLD Podcast is back and better than ever! Tune into the first episode of Season 2 to hear the news you might have missed, exclusive extracts from GOLD's catalyst interview with Judy Stewart, Senior Vice President and Head of US Vaccines, GSK, as well as a fascinating conversation with Independent Pharma Broker and blockchain enthusiast, Vincent Steine.   Click here to subscribe to the weekly...

We're back! The next season of the GOLD Podcast launches on 15 th  February with a brand new format, more high profile guests and fresh industry insights – subscribe now to be the first to join hosts Marc and Helena and hear new episodes.

For the season finale of the GOLD Podcast, we look back at our 'GOLD Medal Moments' from the past 12 months, revisiting interviews with some of our top guests. Marc and Helena pick out the most important and challenging topics from 2021, including combatting misinformation, the evolving role of medical affairs, improving access to medicine and producing results in times of crisis.

In this episode, we talk to Margo Warren, Head of Policy at the Access to Medicine Foundation, who offers her thoughts on the ever-present need for global access to medicine. Margo discusses her path into the fight for health equality, the importance of global vaccine distribution, the changing philosophies behind bringing a product to market, and the move from reactive to pre-emptive research and...

Join us in kicking off the new year with a special episode of the GOLD podcast, welcoming back six of our previous guests to share their predictions for what 2022 could bring for the pharmaceutical industry. They discuss a broad spectrum of topics ranging from new tech trends and clinical trial developments, to improvements in diversity and inclusion and patient centricity.

In this special end-of-year round up episode, three of this year's GOLD Podcast guests return to review 2021 in the pharmaceutical industry. They discuss topics ranging from industry reputation to vaccine access, and celebrate and critique the year just past, while also looking ahead to 2022.

In this episode, we talk to Catherine Owen, Head of Major Markets at Bristol Myers Squibb, who discusses her path into the pharmaceutical industry and the upcoming changes to its data policies. Catherine explores the collection and storage of data, how we can ensure data systems are in place for the next pandemic, methods to build a new data culture and her key takeaways from the past year in phar...

This week, we reflect on the highlights from the pharmaceutical industry that took place in November, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, the standout awareness campaigns, and the latest in research and development news.

We talk to Tamika Jean-Baptiste, Vice President and Chief Diversity Officer, Amgen, who discusses her lifelong passion for diversity both in the workplace and in life. Tamika explores the importance of aligning your purpose and your passion, how best to draw young people into pharma, leveraging employee resource groups, and the significance of filling your own cup before reaching for others.

We speak to Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology about her pathway into men's health, the challenges and potential solutions in the realm of prostate disease, and her advice for family and caregivers on how best to support a loved one who is dealing with a prostate cancer diagnosis.

We talk to Dr Richard Kaszynski, Chief Medical Officer, AiPharma, who discusses the emerging role of antivirals in healthcare. He explores his work on the GUARDIAN program, the benefits of drug repurposing, the importance of keeping patients out of hospitals and his highlights from the past year.

This week, Tanja Dowe, CEO, Debiopharm Innovation Fund, discusses her passion for digital health tools. Drawing on her experience of investing in health technologies, she explores what it takes to be a successful entrepreneur, how these tools could improve life expectancies in cancer, and her highlights from a year of digital transformation for the pharmaceutical industry. 

This week, we take a look back at the standout moments in the pharmaceutical industry from October, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.

We talk to Dr Emma Roffe, Oncology Country Head, Takeda UK, and Eric Low, Founder, Myeloma UK, about the challenge of combination treatments. The two discuss a pair of whitepapers recently produced by Takeda, which uncover why challenges exist, why for so long it has been classified as 'too hard to solve', as well as potential solutions that could revolutionise this area of healthcare. Disclaimer:...

We talk to Massimiliano Siciliano, Digital Solution Director Europe, Novartis, about the potential of digital solutions for the pharmaceutical industry's stakeholders and commercial teams, the technology he is most excited about within pharma's digital revolution, and his three key principles for building high performing teams.

We talk to Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen. She shares her perspective on the industry's drug pricing challenges and opportunities, details alternative pricing systems that could improve access in low-to-middle-income countries, and explores the shifting market access landscape within oncology.

This week, we look back at the highlights in pharma throughout September, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, marketing standouts, and the latest in research and development news.

We talk to Matt Atkinson, Global Projects Director, Reuters Events Pharma, and Megan Reutin, Global Head of Omnichannel Analytics, Grünenthal Group, about the upcoming Reuters Pharma 2021 Event. We get a sneak peek into the event's line-up, consider the future of virtual events, and explore the rapid digital transformation that has taken place over the past year.

We talk to Julie Ross, President, Advanced Clinical, about gender parity in the workplace in aid of International Equal Pay Day. In the discussion, she covers her journey to leadership, the importance of determination and resilience, and why gender parity in healthcare and life sciences is so essential. 

We talk to Carol Lynch, Chief Business Officer, Sandoz, about how to increase the number of women in leadership positions in the pharmaceutical industry, the importance of mental health provisions in the workplace, and Sandoz's role in increasing access to biosimilars around the world.

We talk to Keren Leshem, Chief Executive Officer, OCON Healthcare about how she transformed OCON's business strategy, the importance of educating women on their health and options, and how being mentored as well as acting as a mentor has shaped her career and outlook.

This week, we reflect on the highlights in pharma throughout August, covering the latest in COVID-19 therapy developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.

This week, we talk to Edmond Chan, Senior Director, EMEA Therapeutic Area Lead, Haematology, Janssen, about the impact medical affairs can have on improving patient outcomes. He discusses the different approaches required to engage HCPs working in diabetes, immunology, and haematology, how to advance precision medicine, and steps that can be taken to improve the quality of life of those undergoing...